LEAMINGTON, ON, May 26, 2020 /CNW/ - PRESS RELEASE - Aphria Inc., a global cannabis company, has announced that it will transfer its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq), effective Friday, June 5, 2020, after the market close. The company expects its common stock will begin trading as a Nasdaq-listed security at market open on Monday, June 8, 2020, and will continue to be listed under the ticker symbol "APHA." This transition will not impact the company's primary listing on the Toronto Stock Exchange (TSX: APHA).
"We are excited to have Nasdaq as our new exchange partner. This move is a reflection of our ongoing commitment to find cost effective ways of operating so we can continue to deliver long-term value to shareholders," said Irwin D. Simon, Chief Executive Officer. "Additionally, as a purpose driven company, we believe Nasdaq will be a good fit for Aphria, particularly given our focus on, and the progress we have made, integrating ESG practices across our business."
"With over 76% of Nasdaq-listed companies reporting on at least one ESG metric, we welcome Aphria to the Nasdaq family as they strive to integrate ESG best practices across their business and add strategic value to all of their stakeholders," said Bob McCooey, Global Head of Capital Markets, Nasdaq.
The last day of trading of the company's common stock on NYSE is expected to be Friday, June 5, 2020.
Latest from Cannabis Business Times
- Cannabis Industry Reacts to Biden’s Rescheduling Announcement
- As Predicted, 4/20 Sales Surged During Cannabis Industry Holiday Weekend
- DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption
- Nature's Miracle, Agrify Sign Definitive Merger Agreement
- 5 Things to Confirm When Signing a Cannabis Facility Construction Agreement
- Ziel Partners With Portocanna, Receives 1st EU GMP Certification for Microbial Control Technology in Cannabis
- White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says
- SOMAÍ Group, and Its Subsidiary, RPK Biopharma Expand Cookies Partnership to Include Europe and the UK